EFDID: 53126EFD: View Filing

Issuer: Cahaba Pharmaceuticals, LLC (0001460300) - D

Accession: 0001460300-12-000001 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001460300
  • Entity Name:
    Cahaba Pharmaceuticals, LLC
  • Entity Type:
    Limited Liability Company
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Within 5 years (2008)
  • Address:
    103 Carnegie Center
    Suite 300
    Princeton, NJ 08540
  • Persons:
    Related Persons 3
    Andrew P. Aromando
    Executive Officer
    Madding King, III
    Executive OfficerDirector
    J. Rainer Twiford
    Executive OfficerDirector
EDGAR: Offering Information
  • Accession Date:
    03/22/2012
  • First Sale Date:
    03/07/2012
  • Offering Amount:
    Indefinite
  • Amount Sold:
    $250,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Debt
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
Julio A. Marquez 2261430 Gottbetter Capital Markets, LLC 20680 AL, CA, CO, CT, NJ, NY, PA, TX
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Cahaba Pharmaceuticals, LLC/s/ Andrew P. AromandoAndrew P. AromandoChief Executive Officer2012-03-22